Adicon Holdings Limited (HKG:9860)
Hong Kong · Delayed Price · Currency is HKD 5.24
+0.02 (0.38%)
At close: Jan 30, 2026
Adicon Holdings Revenue
Adicon Holdings had revenue of 1.27B CNY in the half year ending June 30, 2025, a decrease of -22.72%. This brings the company's revenue in the last twelve months to 2.72B, down -12.84% year-over-year. In the year 2024, Adicon Holdings had annual revenue of 2.91B, down -11.64%.
Revenue (ttm)
2.72B CNY
Revenue Growth
-12.84%
P/S Ratio
1.25
Revenue / Employee
527.85K CNY
Employees
5,151
Market Cap
3.71B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.91B | -383.72M | -11.64% |
| Dec 31, 2023 | 3.30B | -1.56B | -32.15% |
| Dec 31, 2022 | 4.86B | 1.48B | 43.83% |
| Dec 31, 2021 | 3.38B | 637.78M | 23.26% |
| Dec 31, 2020 | 2.74B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 5.58B |
| Kindstar Globalgene Technology | 998.42M |
| Yunkang Group | 706.95M |
| Biosino Bio-Technology and Science Incorporation | 246.61M |
| Mega Genomics | 174.76M |
| Guanze Medical Information Industry (Holding) | 161.70M |
| King International Investment | 77.50M |
| China Biotech Services Holdings | 76.93M |